Response to Infliximab in Crohn’s Disease: Genetic Analysis Supporting Expression Profile

Substantial proportion of Crohn’s disease (CD) patients shows no response or a limited response to treatment with infliximab (IFX) and to identify biomarkers of response would be of great clinical and economic benefit. The expression profile of five genes (S100A8-S100A9, G0S2, TNFAIP6, and IL11) rep...

Full description

Saved in:

Bibliographic Details
Main Authors:	Luz María Medrano, Carlos Taxonera, Cristina González-Artacho, Virginia Pascual, María Gómez-García, Manuel Barreiro-de Acosta, José L. Pérez-Calle, Fernando Bermejo, Antonio López-Sanromán, Dolores Martín Arranz, Javier P. Gisbert, Juan Luis Mendoza, Javier Martín, Concepción Núñez, Elena Urcelay
Format:	Article
Language:	English
Published:	Wiley 2015-01-01
Series:	Mediators of Inflammation
Online Access:	http://dx.doi.org/10.1155/2015/318207
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Refractory Crohn’s Disease of the Vulva Treated with Infliximab: A Case Report
by: Sapna Makhija, et al.
Published: (2007-01-01)

Infliximab for Crohn's Disease: More Questions than Answers
by: Hugh James Freeman
Published: (2001-01-01)

Does Smoking Reduce Infliximab’s Effectiveness against Crohn’s Disease?
by: Neeraj Narula, et al.
Published: (2009-01-01)

Pulmonary Mucormycosis in a Patient with Crohn Disease on Immunosuppressive Medications including Infliximab
by: Alissa J Wright, et al.
Published: (2013-01-01)

Crohn's Disease Associated with Sweet's Syndrome and Sjögren's Syndrome Treated with Infliximab
by: Erina N. Foster, et al.
Published: (2005-01-01)

Infliximab Combined with Enteral Nutrition for Managing Crohn’s Disease Complicated with Intestinal Fistulas
by: Xiao-Li Wu, et al.
Published: (2016-01-01)

Exclusive Enteral Nutrition versus Infliximab in Inducing Therapy of Pediatric Crohn’s Disease
by: Youyou Luo, et al.
Published: (2017-01-01)

Canadian Association of Gastroenterology Clinical Practice Guidelines: The Use of Infliximab in Crohn's Disease
by: Remo Panaccione, et al.
Published: (2004-01-01)

Canadian Association of Gastroenterology Clinical Practice Guidelines: The Use of Infliximab in Crohn's Disease
Published: (2001-01-01)

Improvement of Lumbar Bone Mass after Infliximab Therapy in Crohn’s Disease Patients
by: Marina Mauro, et al.
Published: (2007-01-01)

Health Care Resource Use and Costs for Crohn’s Disease before and after Infliximab Therapy
by: Dustin E Loomes, et al.
Published: (2011-01-01)

Funding the New Biologics – CCOHTA Report on the Cost Effectiveness of Infliximab for Crohn’s Disease: Pearls and Pitfalls
by: John K Marshall
Published: (2002-01-01)

Effects of infliximab biosimilar on retinal microvasculature in Crohn’s disease patients evaluated by optical coherence tomography angiography
by: Hesham M. El Mazar, et al.
Published: (2025-01-01)

Funding the New Biologics – A Health Economic Critique of the CCOHTA Report: Infliximab for the Treatment of Crohn’s Disease
by: Craig R Mitton
Published: (2002-01-01)

Outcomes of Pediatric Patients with Crohn’s Disease Received Infliximab or Exclusive Enteral Nutrition during Induction Remission
by: Yao Lv, et al.
Published: (2022-01-01)

Antitumor Necrosis Factor-Alpha (TNF-α) Infliximab-Induced Pleural Effusion and Pericarditis in Crohn’s Disease
by: Ashley Fonseca, et al.
Published: (2021-01-01)

Metastatic Hepatocellular Carcinoma in a Patient with Crohn’s Disease Treated with Azathioprine and Infliximab: A Case Report and Literature Review
by: Kyle J. Fortinsky, et al.
Published: (2014-01-01)

Long Term Safety of Infliximab
by: Thomas F Schaible
Published: (2000-01-01)

Response of Fibroblastic Rheumatism to Infliximab
by: Ricardo Romiti, et al.
Published: (2009-01-01)

Assembling Reading and Writing in the Face of Loss: Christa Couture’s How to Lose Everything and Dakshana Bascaramurty’s This Is Not the End of Me
by: Lola Artacho-Martín
Published: (2025-01-01)

The Safety of Infliximab Infusions in the Community Setting
by: James Ducharme, et al.
Published: (2010-01-01)

All That Bleeds Is Not Infliximab-Refractory Ulcerative Colitis
by: JK Law, et al.
Published: (2009-01-01)

Infliximab Induces Increase in Triglyceride Levels in Psoriatic Arthritis Patients
by: Karla R. Castro, et al.
Published: (2011-01-01)

Review and Clinical Perspectives for the Use of Infliximab in Ulcerative Colitis
by: Remo Panaccione, et al.
Published: (2008-01-01)

Pericardial Effusion due to Infliximab Therapy for Ulcerative Colitis
by: Muhammad Mirza, et al.
Published: (2018-01-01)

Nuevos canales de comunicación institucional en materia de seguridad
by: María Julia Bordonado Bermejo, et al.
Published: (2022-02-01)

Predictors of infliximab efficacy in patients with severe attack of ulcerative colitis
by: A. O. Golovenko, et al.
Published: (2013-10-01)

Pulmonary Embolism following Cessation of Infliximab for Treatment of Miliary Tuberculosis
by: Brian Lee, et al.
Published: (2014-01-01)

Granulomatous Hepatitis Secondary to Histoplasma Infection after Treatment with Infliximab
by: L. Barrera, et al.
Published: (2013-01-01)

The Successful Use of Infliximab in a Relapsing Case of Susac’s Syndrome
by: Suran L. Fernando, et al.
Published: (2020-01-01)

A Severe Case of Ipilimumab-Induced Ileocolitis Refractory to Glucocorticosteroids and Infliximab
by: Behdod Poushanchi, et al.
Published: (2018-01-01)

A Case of Phlegmonous Gastritis in a Patient with Psoriatic Arthritis on Infliximab
by: Laurence De Davide, et al.
Published: (2018-01-01)

Infliximab Salvage Therapy after Cyclosporine in an Acute Flare of Chronic Ulcerative Colitis
by: ECS Lam, et al.
Published: (2003-01-01)

A Case of Immunotherapy-Induced Colitis Complicated by Perforation and Treated with Infliximab Postoperatively
by: Lukas Delasos, et al.
Published: (2019-01-01)

Impacto del COVID-19 en la regulación y operación de actos contractuales en México
by: Roberto Sanromán Aranda
Published: (2021-01-01)

Effectiveness and Safety of Infliximab in Two Cases of Severe Chondrocalcinosis: Nine Years of Follow-Up
by: Jácome Bruges-Armas, et al.
Published: (2014-01-01)

Catheter-Related Acremonium kiliense Fungemia in a Patient with Ulcerative Colitis under Treatment with Infliximab
by: Fernando A. Díaz-Couselo, et al.
Published: (2011-01-01)

Adaptive Immunity in Ankylosing Spondylitis: Phenotype and Functional Alterations of T-Cells before and during Infliximab Therapy
by: Balázs Szalay, et al.
Published: (2012-01-01)

Management of Crohn’s Disease
by: MRB Keighley
Published: (1993-01-01)

Recurrence in Crohn’s Disease
by: Adrian J Greenstein
Published: (1993-01-01)